Almac Diagnostic Services is delighted to have received confirmation that we have been selected as a finalist in this year’s coveted Scrip Awards.
Our unique claraT solution has been recognised within the Innovation category.
Confirmed finalists in Innovation award category winner (sponsored by MSD) are:
MSD – Innovation Award
Achilles Therapeutics clonal neoantigen T-cells (cNeT) for cancer
Almac claraT Gene Expression Report
Arvinas Proteolysis Targeting Chimeras (PROTAC) protein degradation technology
BenevolentAI artificial intelligence for the discovery of more effective medicines
Boundless Bio extrachromosomal DNA (ecDNA)-targeting technology for cancer
Ionis Pharmaceuticals RNA-targeted therapeutics for Huntingdon’s disease
The virtual finals event takes place on Wednesday 2nd December.